Home > Products > CD28 & CD44 > Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem Diabody)

Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem Diabody)  (CAT#: T-BSDB-057)

Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
Datasheet INQUIRY

Specifications

Targets
CD28 & CD44
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Glioblastoma; Squamous cancer

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
CD44
Gene ID
UniProt ID
Alternative Names
CD44; CD44 antigen; ECMRIII; Extracellular matrix receptor III; HCAM; Homing cell adhesion molecule; Pgp-1; phagocytic glycoprotein-1; HUTCH-1; Ly-24; Pgp-1; HERMES; AU023126; AW121933; AW146109
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD28 & CD44"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem Diabody) (T-BSDB-057). Click the button below to contact us or submit your feedback about this product.